Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients.

Med · 2022 · PMC8767655 · PMID 35072129

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The level of neutralizing antibodies was also higher in heterologous versus homologous vaccinated individuals even though it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.